41
TITLE: Deletion of the 5 ' exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome
AUTHORS: Maria Joao N Nabais Sa; Nathalie Fieremans; Arjan P M de Brouwer; Rita Sousa; Fernando T E Teixeira e Costa; Maria Jose Brito; Fernanda Carvalho; Marcia Rodrigues; Francisco Teixeira de Sousa; Joana Felgueiras; Fernando Neves; Adelino Carvalho; Umbelina Ramos; Jose Ramon Vizcaino; Susana Alves; Filipa Carvalho ; Guy Froyen; Oliveira, JP ;
PUBLISHED: 2013, SOURCE: JOURNAL OF MEDICAL GENETICS, VOLUME: 50, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 17
42
TITLE: Fibrosis: a key feature of Fabry disease with potential therapeutic implications  Full Text
AUTHORS: Frank Weidemann; Maria D Sanchez Nino; Juan Politei; Oliveira, JP ; Christoph Wanner; David G Warnock; Alberto Ortiz;
PUBLISHED: 2013, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 118
43
TITLE: Temporal intradiploic dilative vasculopathy: An additional pathogenic factor for the hearing loss in fabry disease?
AUTHORS: Carla Pinto Moura ; Soares, C; Seixas, D; Ayres Bastos, M; Oliveira, JP ;
PUBLISHED: 2013, SOURCE: JIMD Reports, VOLUME: 7
INDEXED IN: Scopus CrossRef: 2
44
TITLE: Comprehensive Genetic Analysis and Structural Characterization of CYP21A2 Mutations in CAH Patients
AUTHORS: Carvalho, B; Pereira, M; Marques, CJ ; Carvalho, D ; Leao, M; Oliveira, JP ; Barros, A ; Carvalho, F ;
PUBLISHED: 2012, SOURCE: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, VOLUME: 120, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 11
46
TITLE: Functional Transcranial Doppler: Presymptomatic Changes in Fabry Disease
AUTHORS: Elsa Azevedo ; Amelia Mendes; Daniela Seixas ; Rosa Santos; Pedro Castro ; Margarida Ayres Basto; Bernhard Rosengarten; Oliveira, JP ;
PUBLISHED: 2012, SOURCE: EUROPEAN NEUROLOGY, VOLUME: 67, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 21
48
TITLE: P24—Prognostic Indicators of Renal Disease Progression: Natural History Data From the Fabry Registry  Full Text
AUTHORS: Wanner, C; Oliveira, JP ; Ortiz, A; Mauer, M; D.P Germain; G.E Linthorst; A.L Serra; Maródi, L; Mignani, R; Cianciaruso, B; Vujkovac, B; Lemay, R; Beitner-Johnson, D; Waldek, S; D.G Warnock;
PUBLISHED: 2012, SOURCE: Clinical Therapeutics, VOLUME: 34, ISSUE: 4
INDEXED IN: CrossRef
49
TITLE: Peripheral Blood Cytopenias and Spleen Pathology  Full Text
AUTHORS: Oliveira, JP ;
PUBLISHED: 2012, SOURCE: Clinical Therapeutics, VOLUME: 34, ISSUE: 4
INDEXED IN: CrossRef
50
TITLE: Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation
AUTHORS: Warnock, DG; Ortiz, A; Mauer, M; Linthorst, GE; Oliveira, JP ; Serra, AL; Marodi, L; Mignani, R; Vujkovac, B; Beitner Johnson, D; Lemay, R; Cole, JA; Svarstad, E; Waldek, S; Germain, DP; Wanner, C;
PUBLISHED: 2012, SOURCE: NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 27, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
Page 5 of 11. Total results: 109.